mhcp-authorization-availity-submission-faq.pdf
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 1651 - 1660 ee natiijooyinka 3289
Bixiye
QP1-24 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective March 1, 2024
Taariikhda uu dhaqangalayo Barnaamijka: Jan 10, 2024
Bixiye
QP2-24 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective February 1, 2024
Taariikhda uu dhaqangalayo Barnaamijka: Jan 10, 2024
Bixiye
QP3-24 UzObi Partnership to Offer Medical BLUEPRINT™
Taariikhda uu dhaqangalayo Barnaamijka: Jan 10, 2024
Bixiye
QP4-24 Blue Cross to End Collaboration with VillageHealth
Taariikhda uu dhaqangalayo Barnaamijka: Jan 10, 2024
Bixiye
P1-24 eviCore Healthcare Specialty Utilization Management (UM) Program: Medical Oncology Drug Prior Authorization Updates
Taariikhda uu dhaqangalayo Barnaamijka: Jan 02, 2024
Bixiye
P2-24 New Practitioner Credentialing Requirements Beginning in 2024
Taariikhda uu dhaqangalayo Barnaamijka: Jan 02, 2024
Bixiye
P3-24 MinnesotaCare Tax Change Effective January 1, 2024
Taariikhda uu dhaqangalayo Barnaamijka: Jan 02, 2024
Bixiye
P4-24 New Medical, Medical Drug and Behavioral Health Policy Management Updates, Effective March 4, 2024
Taariikhda uu dhaqangalayo Barnaamijka: Jan 02, 2024